A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7068 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2459469
The present invention relates to an agent for the prophylaxis or treatment of diabetic neuropathy, which contains cytidine 5'-diphosphocholine (CDP-choline) as an active ingredient. The agent for the prophylaxis or treatment of diabetic neuropathy of the present invention is effective for neuropathy mainly caused by metabolic disturbance of carbohydrate and is also superior in safety. Neuropathy includes peripheral neuropathy and dysautonomia. CDP-choline is effective even by oral administration.
Cette invention se rapporte à des agents prophylactiques/thérapeutiques pour traiter la neuropathie diabétique, qui contiennent comme principe actif de la cytidine 5'-diphosphocholine (CDP-choline). Ces agents prophylactiques/thérapeutiques pour traiter la neuropathie diabétique sont efficaces contre toute neuropathie causée essentiellement par des dysfonctionnements du métabolisme des hydrocarbonates et ont un niveau de sécurité élevé. Le terme neuropathie couvre la neuropathie périphérique et la neuropathie du système nerveux autonome. La CDP-choline est efficace également en administration par voie orale.
Abiru Toichi
Endo Kazuki
Kamei Junzo
Fetherstonhaugh & Co.
Yamasa Corporation
LandOfFree
Pharmaceutical composition for diabetic neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for diabetic neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for diabetic neuropathy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1551412